US Stock MarketDetailed Quotes

LENZ LENZ Therapeutics

Watchlist

25.640
-0.890-3.35%

Close Mar 28 16:00 ET

25.640
0.0000.00%

Post 16:05 ET

706.20MMarket Cap-10.96P/E (TTM)

LENZ Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

LENZ Therapeutics Q4 2024 Earnings Date

Currency：USDMar 19, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
EPS	-0.41	-0.46	-0.05
Miss Est.	--	+50.42%	-11.33%
Net Income	--	-12.65M	--
		+46.60%

Analyst Rating

Strong Buy

Mar 21, 2025

LENZ Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 0.000	--
--	2025/Q1	-- / 0.000	--
Mar 19, 2025	2024/Q4	0.000 / 0.000	--
Nov 6, 2024	2024/Q3	0.000 / 0.000	--
Aug 14, 2024	2024/Q2	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 0.000--

--2025/Q1-- / 0.000--

Mar 19, 20252024/Q40.000 / 0.000--

Nov 6, 20242024/Q30.000 / 0.000--

Aug 14, 20242024/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

LENZ Therapeutics Earnings Reports

LENZ Therapeutics | 10-K: Annual report

Mar 19 16:38 ET

LENZ Therapeutics | 8-K: LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

Mar 19 16:09 ET

LENZ Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 6, 2024 07:37 ET

LENZ Therapeutics | 8-K: LENZ Therapeutics Reports Third Quarter 2024 Financial Results

Nov 6, 2024 07:27 ET